Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | PSMB1 | P20618 | 6/20 | 0.46 |
| ▸ | PSMB5 | P28074 | 5/20 | 0.46 |
| ▸ | PSMB2 | P49721 | 4/20 | 0.46 |
| ▸ | LTA4H | P09960 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | THRB | P10828 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.44 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.44 |
| ▸ | DRD4 | P21917 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19902561 | 0.98 | SMN1; SMN2 (0.46) | KDM4ESMN1; SMN2GAAPSMB1PSMB5 | |
| SCHEMBL19902320 | 0.92 | GAA (0.46) | KDM4ESMN1; SMN2GAALTA4HALDH1A1 | |
| SCHEMBL19997286 | 0.90 | SMN1; SMN2 (0.60) | KDM4ESMN1; SMN2GAAPSMB1PSMB5 | |
| SCHEMBL17324759 | 0.90 | MAOB (0.51) | KDM4EPSMB1PSMB5PSMB2LTA4H | |
| SCHEMBL15897907 | 0.87 | LTA4H (0.49) | KDM4ESMN1; SMN2PSMB1PSMB5PSMB2 | |
| SCHEMBL17454384 | 0.87 | TSHR (0.48) | KDM4EPSMB1PSMB5PSMB2LTA4H | |
| SCHEMBL15882946 | 0.87 | KDM4E (0.50) | KDM4EPSMB1PSMB5PSMB2LTA4H | |
| SCHEMBL17321453 | 0.86 | KDM4E (0.48) | KDM4EPSMB1PSMB5PSMB2LTA4H | |
| SCHEMBL19902594 | 0.86 | KDM4E (0.40) | KDM4ESMN1; SMN2GAALTA4HALDH1A1 | |
| SCHEMBL19675530 | 0.85 | KDM4E (0.50) | KDM4EPSMB1PSMB5PSMB2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10829501-B2 | Spiroheptane salicylamides and related compounds as inhibitors of ROCK | BRISTOL-MYERS SQUIBB COMPANY (US) | 2020-11-10 | — | — | US | disclosed |
| US-20200131200-A1 | SPIROHEPTANE SALICYLAMIDES AND RELATED COMPOUNDS AS INHIBITORS OF ROCK | BRISTOL MYERS SQUIBB CO (US) | 2020-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10829501-B2 | Spiroheptane salicylamides and related compounds as inhibitors of ROCK | ROCK1, MYLK, RHOA | KDM4E 2121/4885SMN1; SMN2 823/4885GAA 4081/4885 |
| US-20200131200-A1 | SPIROHEPTANE SALICYLAMIDES AND RELATED COMPOUNDS AS INHIBITORS OF ROCK | ROCK1, MYLK, RHOA | KDM4E 2121/4885SMN1; SMN2 823/4885GAA 4081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.